Wanbury is all set to launch two new products, for formulation (Branded generic) div., Branded Hematinic Iron tablets WANBURY C-RED and for API (Bulk Drug) div - launching KETAMINE HYDROCHLORIDE.
Wanbury held strong equity in gynecology segment, to capitalize on the same, the company is launching -- WANBURY C-RED. It is an iron supplement, which helps improving hemoglobin in the blood of individuals especially during pregnancy. The Ketamine is developed by a unique cost competitive process & quality product by In - house R&D team in compliance with all the major pharmacopeia such as USP & EP. Ketamine has annual demand of over 200 tons for both human and veterinary market. Ketamine is used to promote sleep before & during surgeries. The company is commencing supply of Ketamine during this month with export for European markets.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: